Neutrophils infiltrate the site of infection and play critical roles in host defense, especially against extracellular bacteria. In the present study, we found a rapid and transient production of IL-17 after i.p. infection with Escherichia coli, preceding the influx of neutrophils. Neutralization of IL-17 resulted in a reduced infiltration of neutrophils and an impaired bacterial clearance. Ex vivo intracellular cytokine flow cytometric analysis revealed that γδ T cell population was the major source of IL-17. Mice depleted of γδ T cells by mAb treatment or mice genetically lacking Vδ1 showed diminished IL-17 production and reduced neutrophil infiltration after E. coli infection, indicating an importance of Vδ1+ γδ T cells as the source of IL-17. It was further revealed that γδ T cells in the peritoneal cavity of naive mice produced IL-17 in response to IL-23, which was induced rapidly after E. coli infection in a TLR4 signaling-dependent manner. Thus, although γδ T cells are generally regarded as a part of early induced immune responses, which bridge innate and adaptive immune responses, our study demonstrated a novel role of γδ T cells as a first line of host defense controlling neutrophil-mediated innate immune responses.
We previously reported that resident γδ T cells in the peritoneal cavity rapidly produced IL-17 in response to Escherichia coli infection to mobilize neutrophils. We found in this study that the IL-17-producing γδ T cells did not produce IFN-γ or IL-4, similar to Th17 cells. IL-17-producing γδ T cells specifically express CD25 but not CD122, whereas CD122+ γδ T cells produced IFN-γ. IL-17-producing γδ T cells were decreased but still present in IL-2- or CD25-deficient mice, suggesting a role of IL-2 for their maintenance. IFN-γ-producing CD122+ γδ T cells were selectively decreased in IL-15-deficient mice. Surprisingly, IL-17-producing γδ T cells were already detected in the thymus, although CD25 was not expressed on the intrathymic IL-17-producing γδ T cells. The number of thymic IL-17-producing γδ T cells was peaked at perinatal period and decreased thereafter, coincided with the developmental kinetics of Vγ6+Vδ1+ γδ T cells. The number of IL-17-producing γδ T cells was decreased in fetal thymus of Vδ1-deficient mice, whereas Vγ5+ fetal thymocytes in normal mice did not produce IL-17. Thus, it was revealed that the fetal thymus-derived Vγ6+Vδ1+ T cells functionally differentiate to produce IL-17 within thymus and thereafter express CD25 to be maintained in the periphery.
IntroductionConventional TCR ␣ cells are exported from the thymus as naive T cells. After activation by exposure to their cognate antigens in the periphery, naive CD4 ϩ ␣ T cells differentiate into different helper T-cell lineages such as Th1, Th2, and Th17 cells, depending on the cytokine milieu, which induce different combinations of transcription factors. STAT3, ROR␥t, and ROR␣, which are induced by combined signals from TGF and IL-6 receptors, play important roles in the differentiation of Th17 cells by binding to the promoter or the enhancer region of the IL17 gene. 1-3 STAT3 also inhibits the expression of Foxp3, which suppresses the functions of ROR␥t. 4 In addition to Th17 cells, several subsets of T cells produce IL-17. These include T cells lacking CD4 and CD8, CD8 ϩ T cells, invariant natural killer T cells (NKT cells), and TCR ␥␦ T cells. [5][6][7][8] There is accumulating evidence that TCR ␥␦ T cells could be the major source of IL-17 in various murine models of infection such as Mycobacterium tuberculosis, Escherichia coli, and Listeria monocytogenes. 9 IL-17-producing ␥␦ T cells are also involved in the pathogenesis of autoimmune diseases such as experimental allergic encephalomyelitis, collagen-induced arthritis, chronic granulomatous disease, and ischemic brain injury. 10 Interestingly, even freshly isolated ␥␦ T cells from the thymus produce IL-17 in response to phorbol myristate acetate (PMA) and ionomycin stimulation, indicating the functional differentiation within the thymus. 11 Such naturally occurring IL-17-producing ␥␦ T cells were already detected at the fetal stage as early as on embryonic day 15 (E15), when ␥␦ T cells began to develop. 11 Therefore, in ␥␦ T cells, the development and functional differentiation to IL-17 producers coincidentally occur within the fetal thymus. Intrathymic functional differentiation has been well documented for NKT cells. 12 During intrathymic development, NKT cell precursors acquire either an IL-4-or an IFN-␥-producing function at different stages. 13 Furthermore, there is a population of NKT cells that differentiates into IL-17-producing cells in the thymus independently of 14 Nevertheless, like Th17 cells, IL-17-producing NKT cells require ROR␥t for their development. 15 At present, the molecular mechanisms for the development of IL-17-producing ␥␦ T cells have not been defined, although it has been shown that IL-17-producing ␥␦ T cells developed normally in IL-6-deficient mice but were decreased in the absence of TGF-1. 16,17 In the present study, we found that Hes1, one of the basic helix-loop-helix (bHLH) proteins induced by Notch signaling, was specifically expressed in IL-17-producing ␥␦ T cells. Furthermore, Hes1, rather than STAT3 and ROR␥t, was critically involved in intrathymic development of IL-17-producing ␥␦ T cells. Expression of Hes1 is also important for IL-17 production by ␥␦ T cells in the periphery. Therefore, although Notch signaling is well known for its role in thymocyte development, it also regulates innate functions of ␥␦ T c...
Chronic treatment with calcitonin in osteoporotic patients alleviates the pain associated with this condition by an unknown mechanism. In ovariectomized rats that develop osteoporosis and hyperalgesia, we examined whether a functional change in serotonergic systems in the spinal dorsal horn was involved, using whole-cell recordings from substantia gelatinosa neurons in spinal cord slices and [(3)H]8-hydroxy-2(di-n-propylamino)tetralin ([(3)H]8-OH-DPAT) binding. Hyperalgesia could be attributed to the elimination of presynaptic inhibition by 5-HT of glutamatergic primary C-afferent terminals and an associated decrease in the density of [(3)H]8-OH-DPAT binding sites whose receptors are neither 5-HT(1A)- nor 5-HT(7)-subtype. These changes in serotonergic systems were restored after chronic treatment with calcitonin. Reversal of 5-HT receptor changes by calcitonin treatment may provide an explanation for its analgesic actions in patients.
Antiviral immune responses play as a double edged sword in resolution of infection and pathogenesis of acute lung injury caused by infection with highly pathogenic influenza A viruses. Here we show that type I interferons (IFNs) are important in protection against acute influenza A virus infection not only via their antiviral activity but also via their anti-inflammatory activity. IFN α receptor (IFNAR) knock-out (KO) mice exhibited increased mortality and morbidity with higher viral load after infection with influenza virus A/FM/1/47 (H1N1, a mouse-adapted strain) compared with wild-type (WT) mice, though the viruses were finally eliminated in both groups. The levels of proinflammatory cytokines in the lungs were significantly higher, while the level of IL-10 in the lungs was significantly lower in IFNAR KO mice than in WT mice during the course of infection. Restoration of IL-10 during an ongoing virus infection significantly reduced the levels of proinflammatory cytokines and improved mortality of IFNAR KO mice. These results suggest that type I IFNs are responsible not only for direct resolution of viral load but also for suppression of immunopathology caused by influenza A virus through IL-10 production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.